Skip to main content
HairCited

Düşük Seviyeli Lazer Tedavisi için Androgenetik Alopesi

A

58 çalışmaya (7 meta-analyses, 8 RCTs), toplam 11,100 katılımcıyla dayanmaktadır. 49/58 çalışma olumlu etkiler göstermektedir.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'ingredient\u003Dlow\u002Dlevel\u002Dlaser\u0026condition\u003Dandrogenetic\u002Dalopecia'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

Sonuç

Low-level laser therapy has strong, well-established evidence for supporting hair growth in androgenetic alopecia, backed by multiple meta-analyses and randomized controlled trials.

  • 49 out of 58 studies show positive effects, supported by 7 meta-analyses and 8 RCTs
  • Stimulates hair follicles through photobiomodulation at specific light wavelengths
  • Included in clinical guidelines as an evidence-based option for pattern hair loss
  • Available as at-home devices (caps, combs, helmets) and clinical in-office systems

Key Study Findings

review
The Use of Light-Based Therapies in the Treatment of Alopecia.
Dose: Low-level light therapy (LLLT) various devices and wavelengths; combined with minoxidil or finasteri vs: Placebo Etki: LLLT improves hair density in AGA; potential to prolong anagen phase in telogen effluvium; may promo None
other n=723
Consensus Recommendations for the Management of Androgenetic Alopecia in Egypt: A Modified Delphi Study.
Dose: None vs: Placebo Etki: 27 consensus statements established across 7 areas: diagnosis, minoxidil, antiandrogens, LLLT, adjuv None
systematic review
Full-Spectrum phototherapy in hair loss management: a systematic review of wavelength-dependent mechanisms, clinical efficacy, and …
Dose: Full-spectrum phototherapy: UVB/UVA, red light, near-infrared (short and long wavelength), mid-infra vs: Placebo Etki: UVB/UVA induces T-cell apoptosis (restoring immune privilege in AA); red light activates mitochondri None
review
The role of microtrauma in hair regrowth and regeneration in non-scarring alopecia.
Dose: Various microtrauma procedures: microneedling, fractional/non-fractional lasers, contact immunothera vs: Placebo Etki: Positive outcomes reported for hair density and thickness with microneedling, lasers, LLLT, and PRP None
randomized controlled trial n=9 12.5 weeks Single-blind
Photobiomodulation therapy and 5% minoxidil in female pattern hair loss: a case series focusing on …
Dose: Photobiomodulation therapy (PBMt; red laser 100mW, 4J/point, 25 sessions, twice weekly) + minoxidil vs: Placebo Etki: Both groups improved QoL and hair density; PBMt + MIN showed significantly greater reduction in telo None

Key Statistics

60

Çalışmalar

11100

Katılımcılar

Positive

A

Derece

Referenced Papers

International journal of … 2024 39 atıf
Journal of clinical … 2024 10 atıf
Facial plastic surgery … 2024 8 atıf
Revue medicale suisse 2024 2 atıf
Clinical, cosmetic and … 2023 58 atıf
American journal of … 2023 41 atıf
Clinics in plastic … 2023 1 atıf
Journal of cutaneous … 2021 44 atıf
Actas dermo-sifiliograficas 2021 3 atıf
Expert opinion on … 2020 147 atıf
Dermatologic therapy 2020 48 atıf
Acta dermatovenerologica Alpina, … 2019 7 atıf
Lasers in surgery … 2017 71 atıf
Actas dermo-sifiliograficas 2017 17 atıf
The Cochrane database … 2016 18 atıf
Facial plastic surgery … 2013 16 atıf

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Yaygın Kullanılan Dozajlar

hairloss:
8-15 minutes, 3x/week

Üst sınır: Not applicable

Araştırmalarda İncelenen Dozajlar

Dozaj Süre Etki N
None -- Positive --
Low-level light therapy (LLLT) various devices and wavelengths; combined with minoxidil or finasteri -- Positive --
None -- Neutral 723
Full-spectrum phototherapy: UVB/UVA, red light, near-infrared (short and long wavelength), mid-infra -- Positive --
Various microtrauma procedures: microneedling, fractional/non-fractional lasers, contact immunothera -- Positive --
Photobiomodulation therapy (PBMt; red laser 100mW, 4J/point, 25 sessions, twice weekly) + minoxidil 12.5 weeks Positive 9
Low-level laser therapy (LLLT) combined with topical minoxidil vs topical minoxidil alone -- Positive --
None -- Positive --

En iyi alım zamanı: Use device for recommended duration 3 times per week on non-consecutive days

Safety & Side Effects

Bildirilen Yan Etkiler

  • Mild scalp warmth or tingling
  • Headache (uncommon)
  • Initial shedding phase (rare)
  • Dry scalp

Bilinen Etkileşimler

  • Photosensitizing medications (tetracyclines, fluoroquinolones) may increase scalp sensitivity
  • No significant interactions with oral hair loss medications

Tolere edilebilir üst alım: Not applicable

Herhangi bir takviye kullanmaya başlamadan önce mutlaka sağlık uzmanınıza danışın.Herhangi bir takviye başlatmadan önce her zaman sağlık uzmanınıza danışın.

Frequently Asked Questions

Does Düşük Seviyeli Lazer Tedavisi help with Androgenetik Alopesi?
Based on 60 studies with 11,100 participants, there is strong evidence from multiple clinical trials that Düşük Seviyeli Lazer Tedavisi may support Androgenetik Alopesi management. Our evidence grade is A (Strong Evidence).
How much Düşük Seviyeli Lazer Tedavisi should I take for Androgenetik Alopesi?
Studies have used various dosages. A commonly studied range is 8-15 minutes, 3x/week. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Düşük Seviyeli Lazer Tedavisi?
Reported side effects may include Mild scalp warmth or tingling, Headache (uncommon), Initial shedding phase (rare), Dry scalp. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Düşük Seviyeli Lazer Tedavisi and Androgenetik Alopesi?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 60 peer-reviewed studies with 11,100 total participants. The overall direction of effect is positive.

Related Evidence

Düşük Seviyeli Lazer Tedavisi diğer sağlık durumları için

FDA Sorumluluk Reddi: Bu ifadeler Gıda ve İlaç Dairesi (FDA) tarafından değerlendirilmemiştir. Bu web sitesindeki ürünler ve bilgiler herhangi bir hastalığı teşhis etmek, tedavi etmek, iyileştirmek veya önlemek amacıyla tasarlanmamıştır. Sunulan kanıt dereceleri, yayımlanmış hakemli araştırmalarımızın analizine dayanmaktadır ve tıbbi tavsiye niteliği taşımamaktadır. Herhangi bir takviye rejimine başlamadan önce her zaman sağlık uzmanınıza danışın.